Skip to main content

Table 1 Characteristics of studies included in the systematic review

From: Antimicrobial susceptibility pattern in non-tuberculous mycobacteria in Iran: a systematic review

Code

First author

Publication

Study period

Sample size

Setting

Province

Sample Origin

DST method

N01 [7]

Moghaddam S

2022

2022

198

Env

Tehran

Teaching hospital waters

CLSI 2011

N02 [8]

Daneshfar S

2022

2019 – 20

50

Cln

Khuzestan, Kermanshah, Tehran, Fars

Pulmonary isolates suspected of NTM from RTB-RLs

CLSI 2011

N03 [9]

Akrami S

2022

2017 – 20

77

Cln

–-

sputum samples of suspected TB

patients from RTB-RL

CLSI 2011

N04 [10]

Dezhkhi S

2021

2019 – 20

92

Cln

Tehran

Patients with TB-like symptoms referred to Hospital

PCR

N05 [11]

Hojatpanah N

2019

–-

10

Cln

Mash'had

Patients from RTB-RL

REMA plate

N06 [12]

Feysia S. G

2020

–-

8

Cln

–-

HIV seropositive patients diagnosed with mycobacterial diseases

CLSI

N07 [13]

Karami-Zarandi

2019

2017 – 19

41

Cln

Tehran

Specimen from RTB-RL

CLSI 2011

N08 [14]

Nasiri M. J

2019

2014 – 18

25

Cln

Tehran

Patients with NTM pulmonary diseases referred to RTB-RL

CLSI 2011

N09 [15]

Khosravi A. D

2018

2016 – 18

95

Cln

Khuzestan, Kermanshah, Hormozgan

pulmonary isolates of NTM from major TB centers

CLSI 2011

N10 [16]

Esfahani B. N

2016

–-

41

Cln + Env

Isfahan

Medical university microbial collection and Water samples

CLSI

N11 [17]

Heidarieh P

2015

–-

88

Cln

Golestan, Isfahan, Kermanshah, Khuzestan, Tehran

Patients with

suspected TB or NTM-related disease

CLSI 2003

N12 [18]

Saifi M

2013

2010 – 11

32

Cln

Tehran

Patients with

suspected TB

–-

N13 [19]

Hashemzadeh M

2023

2019 – 22

50

Cln

Khuzestan,

Tehran,

Kerman,

Isfahan, Fars

Specimen from RTB-RL

CLSI 2011

  1. DST Drug Susceptibility Testing, Cln Clinical, Env Environmental, CLSI Clinical Laboratory Standards Institute, RTB-RL regional TB reference laboratory